The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 01, 2017
Filed:
Jul. 11, 2014
Applicant:
Merck Patent Gmbh, Darmstadt, DE;
Inventors:
Christos Tsaklakidis, Weinheim, DE;
Wolfgang Staehle, Ingelheim, DE;
Birgitta Leuthner, Darmstadt, DE;
Thomas Fuchss, Bensheim-Auerbach, DE;
Assignee:
MERCK PATENT GMBH, Darmstadt, DE;
Primary Examiner:
Int. Cl.
CPC ...
C07D 231/12 (2006.01); C07D 231/54 (2006.01); C07D 233/60 (2006.01); C07D 233/61 (2006.01); C07D 233/64 (2006.01); C07D 233/66 (2006.01); C07D 249/06 (2006.01); C07D 249/08 (2006.01); C07D 401/14 (2006.01); C07D 403/10 (2006.01); C07D 413/10 (2006.01); C07D 413/14 (2006.01); C07D 417/10 (2006.01); C07D 471/04 (2006.01); A61K 31/4164 (2006.01); A61K 31/4178 (2006.01); A61K 31/4192 (2006.01); A61K 31/4196 (2006.01); A61K 31/423 (2006.01); A61K 31/428 (2006.01); A61K 31/437 (2006.01);
U.S. Cl.
CPC ...
C07D 233/61 (2013.01); A61K 31/4164 (2013.01); A61K 31/4178 (2013.01); A61K 31/4192 (2013.01); A61K 31/4196 (2013.01); A61K 31/423 (2013.01); A61K 31/428 (2013.01); A61K 31/437 (2013.01); C07D 231/12 (2013.01); C07D 231/54 (2013.01); C07D 233/60 (2013.01); C07D 233/64 (2013.01); C07D 233/66 (2013.01); C07D 249/06 (2013.01); C07D 249/08 (2013.01); C07D 401/14 (2013.01); C07D 403/10 (2013.01); C07D 413/10 (2013.01); C07D 413/14 (2013.01); C07D 417/10 (2013.01); C07D 471/04 (2013.01);
Abstract
Compounds of the formula I in which R, Y, R, X, X, Xand q have the meanings indicated in claim, are inhibitors of fatty acid synthase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.